
I tweet my stock thoughts 💭 I am not a financial advisor. I like trading small caps. Analyst in @moonmarketo discord disclaimer: https://xitter.gq/t.co/VHth8c33wB
Stocks
Joined December 2023
- Tweets13.7K
- Following173
- Followers8.5K
- Likes13.7K
Pinned Tweet
Guys I will never ask you to join any telegram or ask you for money or any of that. This is my only Twitter account
Replying to @PPortfolioooo
You got someone going around with a fake profile of yours saying join my telegram. If you didn’t already know
PaulsPortfolioooo retweeted
BREAKING: President Trump says he will “work with” states who “want to become rich” from AI.
War ends, inflation down, oil down, rates down— ai/tech fixes their fund “issues” with lower rates. Tech make 100% bounce from lows taking $spy to $800+
One can dream right
PaulsPortfolioooo retweeted
$BDMD 350m volume could be a gapper
Easiest way for the elite to give you a democracy is to let the people “pick”
… they control whoever is there anyway.. they are laughing at us. It’s all an illusion
$NTCL amazing one and thanks @greatstockpicks
$NTCL BOOMING
$NTCL Seriously how do we not get at least 70c here its a 1m float
🤔
$JBDI 900m merger closed today, 200% cost to borrow and just ran to $10 on this news.
highs. beautiful call
$BDMD Under the partnership with Alpmed, Baird Medical is leading global regulatory interactions during the respective review processes, and holds worldwide commercial rights for the IRE system. The companies are targeting potential U.S. FDA 510(k) clearance and EU CE marking in 2027, subject to the outcome of the respective regulatory review processes.
PaulsPortfolioooo retweeted
$BDMD Under the partnership with Alpmed, Baird Medical is leading global regulatory interactions during the respective review processes, and holds worldwide commercial rights for the IRE system. The companies are targeting potential U.S. FDA 510(k) clearance and EU CE marking in 2027, subject to the outcome of the respective regulatory review processes.
$BDMD .11 | Baird Medical and Alpmed Announce FDA 510(k) and EU CE Submissions for Irreversible Electroporation (IRE) System










